Floatz logo

azd8055

Brainstem Glioma

National Cancer Institute (NCI)Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Brainstem Glioma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Julie Krystal
Phase 2BB
Irinotecan
Julie Krystal
Phase 2BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
Mebendazole
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2B
Veliparib
National Cancer Institute (NCI)
Phase 1/2B

View all 32 →

Same molecule, other indications

azd8055 is also rated in:

anaplastic oligodendrogliomaDormant
CC
Indicative ·
47 / 100
View asset →
anaplastic astrocytomaDormant
CC
Indicative ·
44 / 100
View asset →
glioblastomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →